By Neuroscience News –
Researchers have developed a model that quickly converts stem cells to brain cells with Parkinson’s disease (PD) protein structures, allowing for personalized study and treatment. This new approach can transform stem cells into brain cells within weeks, facilitating high-throughput genetic and drug screening.
By mimicking diverse protein misfolding seen in PD patients, the model offers a practical tool for diagnostics and drug discovery. This advancement could lead to personalized therapies for Parkinson’s and related neurodegenerative diseases.